Filing Details
- Accession Number:
- 0001437749-22-016306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-30 17:52:37
- Reporting Period:
- 2022-06-30
- Accepted Time:
- 2022-06-30 17:52:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1742927 | Reviva Pharmaceuticals Holdings Inc. | RVPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829831 | Prabhu Narayan | C/O Reviva Pharmaceuticals Holdings, Inc 19925 Stevens Creek Blvd, Suite 100 Cupertino CA 95014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2022-06-30 | 50,000 | $1.21 | 50,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.37 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
